India, June 8 -- Pre-implantation genetic diagnosis (PGD) is a revolutionary treatment in the field of in vitro fertilization (IVF). It allows genetic screening of embryos before implantation. Couples with known single-gene disorders such as thalassemia, Duchenne muscular dystrophy (DMD), fragile X syndrome, and myotonic dystrophy can be eliminated from the generations with the help of PGD. This technique involves checking the embryos for known genetic disorders, ensuring only healthy embryos are transferred to the uterus. It thus not only improves IVF success rates but also reduces the risk of inherited genetic conditions, offering hope to families suffering from genetic disease. PGT A (pre-implantation genetic testing for aneuploidy) is particularly beneficial for older women or those who have experienced multiple IVF failures. In these cases, embryos can be aneuploid and be the culprit for repeated failures. By testing the chromosome make up of embryos, this technology can select the best embryo for transfer and thus improve success rates and shorten the time to pregnancy. As technology advances, PGD is becoming more precise and accessible, paving the way for more personalised fertility treatments. PGD's role in preventing suffering and enhancing reproductive choice marks a transformative step in modern reproductive medicine. The author of the article is Dr Sheetal Jindal, senior consultant /genetic expert at Jindal IVF, SCO 21, Sector 20D, Dakshin Marg, Chandigarh, who can be contacted at 958-246-9429...